| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 01.09.1998 (9372
dage). |
Ingen historik.
| Branche | | Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900). |
| Sidst opdateret den 10.07.2012 og
angivet som gældende fra 01.01.2011 (4867
dage). |
| Historik | Start | Stop |
|---|
| Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900) | 01.01.2011 | |
| Anden teknisk rådgivning (711290) | 01.01.2008 | 31.12.2010 |
| Anden teknisk rådgivning (742090) | 01.09.1998 | 31.12.2007 |
| Revisionfravalgt | | false. |
| Sidst opdateret den 11.03.2015 og
angivet som gældende fra 01.09.1998 (9372
dage). |
Ingen historik.
| Historik | Start | Stop |
|---|
| sten.verland@synarc.com | 21.05.2001 | 28.11.2001 |
| Virksomheden har ikke ændret Kontakt i sin
levetid. |
Ingen nuværende registrering.
| Telefonnummer | | 44525400. |
| Sidst opdateret den 03.12.2001 og
angivet som gældende fra 29.11.2001 (8187
dage). |
Ingen historik.
| Navne | | Center for Clinical and Basic Research A/S. |
| Sidst opdateret den 26.08.2019 og
angivet som gældende fra 26.08.2019 (1708
dage). |
| Historik | Start | Stop |
|---|
| Center for Clinical and Basic Research A/S | 26.08.2019 | |
| SYNARC A/S | 05.03.1999 | 25.08.2019 |
| DODONA A/S | 01.09.1998 | 04.03.1999 |
| Binavne | | CCBR A/S. |
| Sidst opdateret den 26.08.2019 og
angivet som gældende fra 26.08.2019 (1708
dage). |
| Historik | Start | Stop |
|---|
| CCBR A/S | 26.08.2019 | |
| DODONA A/S | 01.09.1998 | 25.08.2019 |
| Tegningsregel | | Selskabet tegnes af den administrerende direktør i forening med et bestyrelsesmedlem eller af to bestyrelsesmedlemmer i forening. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 05.04.2013 (4042
dage). |
| Fortolkning
(2 tegningsmuligheder)
| | direktøren + 1 bestyrelsesmedlem |
| 2 bestyrelsesmedlemmer + |
Ingen historik.
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:Ecovis Danmark
Revisionsvirksomhedens CVR-nr.:28939523
Beskrivelse af revisor:State Authorized Public Accountant
Virksomhedens regnskabsklasse:Regnskabsklasse C, mellemstor virksomhed
Grundlag for konklusion (revision):We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the “Auditor's responsibilities for the audit of the financial statements” section of our report. We are independent of the company in accordance with the International Ethics Standards Board for Accountants' Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):We have audited the financial statements of Center for Clinical and Basic Research A/S for the financial year 1 January - 31 December 2022, which comprise a summary of significant accounting policies, income statement, balance sheet, statement of changes in equity and notes. The financial statements are prepared under the Danish Financial Statements Act.
In our opinion, the financial statements give a true and fair view of the company's financial position at 31 December 2022 and of the results of the company's operations for the financial year 1 January - 31 December 2022 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on management's review
Management is responsible for management's review.
Our opinion on the financial statements døs not cover management's review, and we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read management's review and, in doing so, consider whether management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.
Moreover, it is our responsibility to consider whether management's review provides the information required under the Danish Financial Statements Act.
Based on the work we have performed, we conclude that management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of management's review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration